Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzhexol for prevention of antipsychotic-induced extrapyramidal symptoms in schizophrenia
ChiCTR2000032700Phase 4Not yet recruiting
- Sponsor
- Chaohu Hospital of Anhui Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of trihexyphenidyl in Extrapyramidal symptoms (EPS) and schizophrenia (2 arms), sponsored by Chaohu Hospital of Anhui Medical University. Primary endpoint: Extrapyramidal Symptom Rating Scale. Planned start May 2020; status: not yet recruiting.
02
Drugs
trihexyphenidyl
03
Conditions
Extrapyramidal symptoms (EPS)schizophrenia
Beyond the preview
Go deeper on ChiCTR2000032700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032700.